Tumor mutational burden is a determinant of immune-mediated survival in breast cancer

Mounting evidence supports a role for the immune system in breast cancer outcomes. The ability to distinguish highly immunogenic tumors susceptible to anti-tumor immunity from weakly immunogenic or inherently immune-resistant tumors would guide development of therapeutic strategies in breast cancer....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Thomas, Alexandra, Routh, Eric D., Pullikuth, Ashok, Jin, Guangxu, Su, Jing, Chou, Jeff W., Hoadley, Katherine A., Print, Cristin, Knowlton, Nick, Black, Michael A., Demaria, Sandra, Wang, Ena, Bedognetti, Davide, Jones, Wendell D., Mehta, Gaurav A., Gatza, Michael L., Perou, Charles M., Page, David B., Triozzi, Pierre, Miller, Lance D.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207420/
https://ncbi.nlm.nih.gov/pubmed/30386679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1490854
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars